GHRP-2 vs GHRP-6: Ghrelin Receptor Agonist Research

GHRP-2 and GHRP-6 are first-generation synthetic ghrelin-receptor (GHS-R) agonists. Both produce a robust GH pulse from pituitary somatotrophs, but they differ in potency, appetite signalling, and off-target hormone release. This comparison summarises the published literature relevant to laboratory research.

At-a-glance comparison

| Attribute | GHRP-2 | GHRP-6 | |---|---|---| | Class | Synthetic GHRP (GHS-R agonist) | Synthetic GHRP (GHS-R agonist) | | GH pulse potency (published) | Higher than GHRP-6 at matched dose | Lower than GHRP-2 at matched dose | | Appetite stimulation | Modest | Pronounced (most appetite-stimulating GHRP) | | Prolactin / cortisol release | Modest elevation reported | Modest elevation reported | | Typical research dosing | 100-300 mcg per administration | 100-300 mcg per administration | | Half-life | ~15-60 minutes | ~15-60 minutes |

Mechanism

Both bind the ghrelin receptor (GHS-R 1a) on pituitary somatotrophs to release GH, and both also suppress somatostatin tone — amplifying the GH pulse beyond what GHRH analogs alone can produce. They are routinely combined with GHRH analogs (sermorelin, CJC-1295, tesamorelin) in published research for additive pulse amplitude.

Published research highlights

• GHRP-2 is generally reported as the more potent GH secretagogue at matched doses.
• GHRP-6 is consistently reported as the most appetite-stimulating GHRP — an effect mediated by central ghrelin-receptor activity in the arcuate nucleus.
• Both elevate cortisol and prolactin modestly, more than ipamorelin (which is the cleanest GHRP for off-target hormone release).

Selecting between them in research

• For maximal GH pulse with minimal appetite signal: GHRP-2.
• For appetite/ghrelin-axis research models: GHRP-6.
• For cleanest off-target profile: ipamorelin (not GHRP-2 or GHRP-6).

Combination research

• Both GHRPs are studied in combination with GHRH analogs. The published combinations include:
• GHRP-2 + CJC-1295 (no-DAC) — pulse-amplitude research
• GHRP-6 + sermorelin — appetite + GH-axis research
• GHRP-2 + tesamorelin — published in lipodystrophy-adjacent research

Frequently asked research questions

Is GHRP-2 always preferred over GHRP-6? No — GHRP-6's pronounced appetite signal is the intended endpoint in ghrelin-axis research.

How do they compare to ipamorelin? Ipamorelin is a later-generation GHRP with cleaner selectivity (minimal prolactin/cortisol). GHRP-2/6 have larger historical research datasets but more off-target hormone release.

Why combine with GHRH analogs? The two receptor classes (GHRH-R and GHS-R) converge on the same somatotroph through distinct signalling cascades, producing additive GH release greater than either alone.

Related research

• CJC-1295 vs Ipamorelin research comparison
• Ipamorelin vs Hexarelin research comparison
• GHRP receptor pharmacology overview